At Aevon, we believe that solving complex global challenges such as aging, neurodegenerative diseases, and human longevity requires collaboration between scientists, researchers, institutions, and technology innovators worldwide.
We are building the infrastructure upon which this future will operate—and we cannot do it alone. Strategic partnerships accelerate discovery, combine expertise, and create breakthroughs that no single entity could achieve independently.
Biological challenges require multidisciplinary teams across biology, AI, medicine, and engineering.
Shared knowledge accelerates discovery years ahead of isolated research.
Partners ensure that advances reach populations everywhere.
Aging mechanisms, healthspan extension, interventions.
Machine learning, biomarkers, drug discovery.
Alzheimer's, Parkinson's, cognitive decline.
Regenerative medicine, gene therapy.
Universities & labs
Medical technologies
Healthcare AI
Hospitals & research centers
Collaborate on studies
Co-develop platforms
Analyze biological data
Trials & studies
Co-author findings
Partner on funding
Aevon aims to build a global research network connecting scientists, technologists, and institutions working to extend healthy human lifespan — accelerating the transition from reactive to predictive medicine.
For direct inquiries, contact our partnerships team: